DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.

Information source: Canadian Retinal Trials Group
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Age-Related Macular Degeneration

Intervention: Triamcinolone Acetonide (Drug)

Phase: Phase 2/Phase 3

Status: Active, not recruiting

Sponsored by: Canadian Retinal Trials Group

Official(s) and/or principal investigator(s):
David A Maberley, M.D., Study Director, Affiliation: University of British Columbia

Summary

A 24 - month Study looking at the the changes in visual acuity of patients receiving PDT

therapy in conjunction with intravitreal triamcinolone.

Clinical Details

Official title: Triamcinolone Acetonide as an Adjunctive Treatment to Verteporfin Therapy in Neovascular Age-Related Macular Degeneration: Randomized Placebo-Controlled Clinical Trial.

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Primary outcome: Changes in visual acuity from baseline.

Secondary outcome: Change in lesion characteristics from baseline.

Detailed description: This study will evaluate the effect of Triamcinolone Acetonide in conjunction with photodynamic therapy for the treatment of sub-foveal choroidal neovascular membranes secondary to age-related macular degeneration.

Eligibility

Minimum age: 50 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Individuals with predominantly classic, subfoveal CNV secondary to AMD.

- No previous PDT Treatment in study eye.

Exclusion Criteria:

- CNV from conditions, other than AMD.

- Other disease that could be responsible for decreased vision.

Locations and Contacts

Eye Care Centre, Vancouver, British Columbia, Canada
Additional Information

Starting date: January 2004
Last updated: July 26, 2007

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017